Companies: 10,795·Total market cap: $144.5T

60 Degrees Pharmaceuticals, Inc.

60 Degrees Pharmaceuticals, Inc.

SXTPNASDAQHealthcare● Active

$1.43

+$0.01(+0.70%)

Market Cap$1153367

P/E Ratio—

52W High$11.84

52W Low$1.29

Avg Volume1.2M

Open$1.45

Beta2.65

Net Income Financials Revenue

60 Degrees Pharmaceuticals, Inc. (SXTP) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

SXTP · net income · updated Jun 9, 2026

Core profitability metrics

SXTP · net income · margin · TTM · CAGR

Net income was −$7.4M for FY2025 (fiscal year ending 2025-12-31), up 7.3% year-over-year. Net profit margin was -732.8%.

FY2025 Net Income−$7.4M▲ +7.3% YoY

Trailing 12M (TTM)−$7.6Mtrailing 4 quarters sum

Net Profit Margin-732.8%−$7.4M ÷ $1.0M

YoY Change+7.3%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · SXTP net income history · SXTP profit margin

Annual net income data

SXTP · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$7.4M▲ +7.3%-732.8%$1.0M

FY2024Loss−$7.9M▼ 111.0%-1308.0%$607,574

FY2023Loss−$3.8M▲ +39.1%-1485.1%$253,573

FY2022Loss−$6.2M▼ 45.4%-2769.5%$223,208

FY2021Loss−$4.3M▼ 40.1%-366.4%$1.2M

Net income vs peers (Healthcare)

SXTP vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

60 Degrees Pharmaceuticals, Inc.YOU

SXTP

−$7.4M+7.3%-732.8%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

60 Degrees Pharmaceuticals, Inc. (SXTP) reported net income of −$7.4M for FY2025 (fiscal year ending 2025-12-31), up 7.3% year-over-year. The net profit margin was -732.8% — meaning the company kept $-7.33 of every dollar of revenue as profit.

60 Degrees Pharmaceuticals, Inc. has not yet achieved annual profitability based on available data (6 fiscal years). The company has reported net losses across all available periods.

60 Degrees Pharmaceuticals, Inc.'s net profit margin was -732.8% for FY2025, based on the latest annual results.

Investors sometimes search for "60 Degrees Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from SXTP net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

SXTP net income · 4 questions

60 Degrees Pharmaceuticals, Inc. is not currently profitable on an annual basis. The company reported a net loss of $7.4M for FY2025.

is SXTP profitabledoes SXTP make a profitSXTP profitabilitySXTP profitable company

▸ Source: FMP /income-statement · GAAP · 60 Degrees Pharmaceuticals, Inc. · 60 Degrees Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026